Trying to separate three different claims about ipamorelin: that it is the right molecule, that it is the right dose, and that it does something useful.
The effect size I actually noticed is roughly a third of what the write-ups imply, and it took two years to be sure.
If you need three other compounds to notice the first one, you have not tested the first one.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Curious whether the popular dose has any basis or is just the convenient one.
Narrow conclusion.
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation. Vivid dreams was my main issue with ipamorelin too.
What is the first thing you would read if you were starting from zero?
Narrow conclusion. Vivid dreams was my main issue with ipamorelin too.
Loose evidence is not nothing, but a washout either side is the only reason to trust your own take.
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid. Not on ipamorelin but the pattern is familiar.
Read methods.
Where does the human data stop and the extrapolation begin? That is the whole thread.
Narrow conclusion. Same for me with ipamorelin, unfortunately.
This is the kind of post the forum exists for.
Sleep, food, or the compound? Yes.
Sterility is the part people wave through and it is the part that actually bites.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
Read methods.